CVS Health Corporation
CVS
$73.15
$1.011.40%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 4.53B | 5.28B | 4.61B | 5.02B | 7.19B |
Total Depreciation and Amortization | 4.63B | 4.61B | 4.60B | 4.58B | 4.55B |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 59.00M | 52.00M | -213.00M | 552.00M | 226.00M |
Change in Net Operating Assets | -1.66B | -1.19B | 109.00M | -5.54B | -3.89B |
Cash from Operations | 7.57B | 8.76B | 9.11B | 4.61B | 8.07B |
Capital Expenditure | -2.79B | -2.82B | -2.78B | -2.92B | -2.80B |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -161.00M | -90.00M | -95.00M | -205.00M | -211.00M |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -2.73B | -3.37B | -4.74B | -5.18B | -2.72B |
Cash from Investing | -5.68B | -6.28B | -7.61B | -8.31B | -5.73B |
Total Debt Issued | 5.79B | 7.31B | 9.83B | 5.76B | 4.16B |
Total Debt Repaid | -5.30B | -6.36B | -4.77B | -2.14B | -1.62B |
Issuance of Common Stock | 324.00M | 302.00M | 361.00M | 377.00M | 385.00M |
Repurchase of Common Stock | -133.00M | -161.00M | -3.21B | -3.21B | -3.21B |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -3.38B | -3.37B | -3.37B | -3.31B | -3.26B |
Other Financing Activities | 11.00M | 36.00M | 26.00M | -13.00M | -110.00M |
Cash from Financing | -2.68B | -2.24B | -1.14B | -2.54B | -3.65B |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -795.00M | 239.00M | 359.00M | -6.24B | -1.31B |